Product Information

BUPROPION HCL XL 150 MG TABLET is a generic product labeled by American Health Packaging, priced at $0.0787 per EA under NDC 60687078201. Its NADAC has been published 124 times since Apr 10, 2024.

FDA first approved this application on Apr 6, 2017. Its Orange Book therapeutic-equivalence code is AB3 — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

BUPROPION HCL XL 150 MG TABLET

Bupropion Hydrochloride
$0.0787per EA

Strength

150 mg/1

NDC

60687078201

Classification

Generic

Dosage Form

TABLET, EXTENDED RELEASE

Route

ORAL

Effective Date

8/19/2026

Active Ingredients

BUPROPION HYDROCHLORIDE

Approval Type

Generic (ANDA)

FDA Application

ANDA090693

FDA Approved

4/6/2017

TE Code

AB3

On Market Since

1/15/2024

Pharmacological Classes

Aminoketone
Dopamine Uptake Inhibitors
Increased Dopamine Activity
Increased Norepinephrine Activity
Norepinephrine Uptake Inhibitors

Price Statistics

The NADAC for BUPROPION HCL XL 150 MG TABLET has been published 124 times since Apr 10, 2024, and over the history we have for it it has declined 35.2%. The table below summarizes its recorded NADAC range and movement.

Current price$0.0787 per EA
All-time high$0.1215 (Apr 10, 2024)
All-time low$0.0745 (Nov 20, 2024)
52-week high$0.1015
52-week low$0.0770
Median price$0.0987
Average price$0.0947
Largest weekly change-30.3% (Nov 20, 2024)
Weeks tracked124
Tracking sinceApr 10, 2024

Price History

1W

+1.2%

1M

+1.1%

3M

-0.3%

6M

+0.2%

1Y

-22.5%

3Y

N/A

5Y

N/A

All

-35.2%

Generic Alternatives

The matcher finds 10 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of BUPROPION HCL XL 150 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for BUPROPION HCL XL 150 MG TABLET, manufactured by American Health Packaging, is $0.0787 per EA (NDC 60687078201), effective Aug 19, 2026.

How has the price of BUPROPION HCL XL 150 MG TABLET changed over time?

Over the history we have for it, the NADAC for BUPROPION HCL XL 150 MG TABLET has declined 35.2%. It has been tracked across 124 weekly CMS publications since Apr 10, 2024.

What are the highest and lowest recorded NADAC prices for BUPROPION HCL XL 150 MG TABLET?

Since Apr 10, 2024, the NADAC for BUPROPION HCL XL 150 MG TABLET has ranged from a low of $0.0745 (Nov 20, 2024) to a high of $0.1215 (Apr 10, 2024), with a median of $0.0987 per EA.

Are there cheaper alternatives to BUPROPION HCL XL 150 MG TABLET?

10 manufacturers publish a NADAC-priced product with the same active ingredient and strength as BUPROPION HCL XL 150 MG TABLET in a comparable dosage form, but none are currently priced below it.

Who manufactures BUPROPION HCL XL 150 MG TABLET?

BUPROPION HCL XL 150 MG TABLET (NDC 60687078201) is labeled by American Health Packaging, and CMS classifies it as a generic product.